Table 1.
Total patients | 74 |
Gender (male/female), n (%) | M/F = 32/42 (M = 43.2%) |
Treatment site (right/left), n (%) | RE/LE = 36/38 (R = 48.6%) |
Age, median (Q1–Q3), years | 64 (30–82) |
Tumor height, median ± SD (Q1–Q3), mm | 5.65±2.61 (1.6–12.1) |
Largest basal diameter, median ± SD (Q1–Q3), mm | 11.83±3.65 (4.1–21.5) |
Local recurrence, median ± SD (Q1–Q3), months | 38.50±26.2 (5–100) |
Total follow-up, mean ± SD (Q1–Q3), months | 54.70±34.20 (13.3–153.6) |
Tumor location as defined by standardized ultrasound | |
Posterior | 20 |
Posteroequatorial | 23 |
Equatorial | 11 |
Anterioequatorial | 9 |
Anterior | 11 |
TNM stage as defined by AJCC classification scheme (8th edition) | |
T1 | 16 |
T2 | 31 |
T3 | 21 |
T4 | 6 |
RE, right eye; LE, left eye; SD, standard deviation.